Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEXTANT 2: Protocolized Antibiotic Care for Severe Open Fractures
NCT04678154Phase 3Recruiting
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- May 2021
- Primary completion
- Sep 2028
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin, tobramycin in surgical site infection (SSI), sponsored by Major Extremity Trauma Research Consortium. Started May 2021; status: recruiting.
02
Drugs
vancomycintobramycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04678154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678154.